Mannatech (NASDAQ:MTEX) Coverage Initiated at StockNews.com

Stock analysts at StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEXGet Free Report) in a research note issued to investors on Tuesday. The brokerage set a “buy” rating on the stock.

Mannatech Trading Down 2.4 %

NASDAQ MTEX opened at $7.56 on Tuesday. The firm’s fifty day moving average price is $8.01 and its 200 day moving average price is $8.46. Mannatech has a 12 month low of $7.30 and a 12 month high of $15.10. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.08 and a quick ratio of 0.56. The company has a market capitalization of $14.21 million, a price-to-earnings ratio of -8.49 and a beta of 1.17.

Mannatech (NASDAQ:MTEXGet Free Report) last posted its earnings results on Tuesday, May 14th. The company reported $0.63 EPS for the quarter. The business had revenue of $29.39 million for the quarter. Mannatech had a negative return on equity of 15.37% and a negative net margin of 1.31%.

About Mannatech

(Get Free Report)

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.

Featured Articles

Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.